# Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients.

> **NCT07129837** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 62 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DIAGNOSTIC_TEST:** Clinical evaluation, disease activity and disability scoring, and laboratory testing including RF, anti-CCP, and serum anti-PCOLCE antibody measurement by ELISA.

## Key facts

- **NCT ID:** NCT07129837
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07129837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07129837, "Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07129837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*